HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Randomized phase II trial of hexamethylmelamine versus pentamethylmelamine in carcinoma of the bilharzial bladder.

AuthorsN Gad-el-Mawla, J L Ziegler, R Hamza, M Elserafi, H Khaled
JournalCancer treatment reports (Cancer Treat Rep) Vol. 68 Issue 5 Pg. 793-4 (May 1984) ISSN: 0361-5960 [Print] United States
PMID6426792 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antineoplastic Agents
  • Triazines
  • Altretamine
  • pentamethylmelamine
Topics
  • Altretamine (adverse effects, analogs & derivatives, therapeutic use)
  • Antineoplastic Agents (therapeutic use)
  • Carcinoma, Squamous Cell (drug therapy)
  • Drug Evaluation
  • Humans
  • Nausea (chemically induced)
  • Random Allocation
  • Schistosomiasis (complications)
  • Time Factors
  • Triazines (therapeutic use)
  • Urinary Bladder Neoplasms (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: